top of page

Modulation of Lipoprotein(a) Atherogenicity by High Density Lipoprotein Cholesterol Levels in Middle-Aged Men With Symptomatic Coronary Artery Disease and Normal to Moderately Elevated Serum Cholesterol fn1fn1This study was supported by Bristol-Myers Squibb Co., Princeton, New Jersey (REGRESS main study) and by Grant 94.032 from the Dutch Heart Foundation, Den Haag, The Netherlands [lipoprotein(a) substudy].
Cobbaert, Christa; Jukema, J.Wouter; Zwinderman, Aeilko H.; Withagen, Adrie J.A.M.; Lindemans, Jan; Bruschke, Albert V.G.
Abstract:
Automatic Tags
bottom of page

